Fluticasone Furoate/Vilanterol Flashcards

Play Quiz

Study Flashcards

Spaced Repetition

Chat to Lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Combination of fluticasone (Glucocorticoid steroids) and vilanterol (beta-2 agonist bronchodilator)

COPD (chronic obstructive pulmonary disease)

Inhalation Signup and view all the answers

C-6 Signup and view all the answers

Nasopharyngitis, upper respiratory infection, headache Signup and view all the answers

Flashcards are hidden until you start studying

Brand name: Breo Ellipta, a widely recognized inhalation medication.
Drug Classification: A combination of fluticasone, a glucocorticoid steroid that reduces inflammation, and vilanterol, a beta-2 agonist bronchodilator that relaxes airway muscles.
Primary Use: Indicated for treating COPD (chronic obstructive pulmonary disease), a progressive lung condition characterized by breathing difficulties.
Dosage Form: Administered via inhalation, allowing for direct delivery to the lungs for effective treatment.
Control Schedule: Classified as C-6, indicating it is a non-controlled substance under federal regulations.
Common Side Effects: May include nasopharyngitis (inflammation of the nasal passages), upper respiratory infections, and headaches; these should be monitored during treatment.